Browse All
Displaying 1 - 1 of 1
Author:Bar-Or, Amit Wiendl, Heinz De Seze, Jerome Correale, Jorge Cross, Anne Derfuss, Tobias Selmaj, Krzysztof Winthrop, Kevin Giacomini, Paul Sacca, Francesco Hu, Xixi Sullivan, Roseanne Jehl, Valentine Boer, Ibolya Bhatt, Alit Hauser, Stephen
Session Name:P9: Multiple Sclerosis: Clinical Trials and Therapeutics (including Safety) 2
Topic:Multiple Sclerosis
Program Number:P9.007
Author Institution:Center for Neuroinflammation and Experimental Therapeutics and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA University of Muenster, Muenster, Germany University Hospital of Strasbourg, Strasbourg, France Institute for Neurological Research Dr. Raul Carrea, Buenos Aires, Argentina Washington University School of Medicine, Clayton, MO Neurology Clinic and Policlinic and Research Center for Clinical Neuroimmunology and Neuroscience, Departments of Medicine and Biomedicine, University Hospital and University of Basel, Basel, Switzerland Center for Neurology, Lodz, Lodz, Poland Public Health and Preventive Medicine, Division of Infectious Diseases, Oregon Health and Sciences University, Portland, OR Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada NSRO Department, University “Federico II” of Naples, Naples, Italy Novartis Pharmaceuticals Corporation, East Hanover, NJ Novartis Pharma AG, Basel, Switzerland Novartis Healthcare Pvt. Ltd., Hyderabad, India UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA
